Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › EGFR and C-Met fibronectin type III domain binding molecules

EGFR and C-Met fibronectin type III domain binding molecules

US Patent 9725497 · Granted Aug 8, 2017

Estimated economic value: $80,530,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

EPCAM binding fibronectin type III domains2025
Proteins comprising CD3 antigen binding domains and uses thereof2025
Combination therapies with bispecific anti-EGFR/c-met antibodies and third gener2025
Serum albumin-binding fibronectin type III domains and uses thereof2025
EGFR and C-met fibronectin type III domain binding molecules2025
EGFR and C-met fibronectin type III domain binding molecules2025
EGFR and C-met fibronectin type III domain binding molecules2025
EGFR and C-met fibronectin type III domain binding molecules2025
EGFR and C-met fibronectin type III domain binding molecules2025
EGFR and C-met fibronectin type III domain binding molecules2025
EGFR and C-met fibronectin type III domain binding molecules2025
EGFR and C-met fibronectin type III domain binding molecules2025